lung disease

Pharma

BI's Jascayd quickly expands lung disease reach with new FDA nod

Boehringer's Jascayd can now crack open the rare progressive pulmonary fibrosis disease market with a second FDA indication following its October launch.

Zoey Becker Dec 22, 2025 12:02pm

Boehringer breaks IPF treatment drought with new FDA approval

Oct 8, 2025 8:56am

United shares surge on Tyvaso win in new lung disease population

Sep 2, 2025 3:34pm

Insmed's Brinsupri nabs landmark FDA nod in chronic lung disease

Aug 12, 2025 12:05pm

Boehringer backs drive to improve bronchiectasis management

Jul 2, 2025 9:23am

Respiratory patient groups decry pricing, access to lung meds

Jul 24, 2023 7:34am